These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 14744975)

  • 21. Tumor necrosis factor-alpha promotes atherosclerotic lesion progression in APOE*3-Leiden transgenic mice.
    Boesten LS; Zadelaar AS; van Nieuwkoop A; Gijbels MJ; de Winther MP; Havekes LM; van Vlijmen BJ
    Cardiovasc Res; 2005 Apr; 66(1):179-85. PubMed ID: 15769461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.
    Bro S; Binder CJ; Witztum JL; Olgaard K; Nielsen LB
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1080-6. PubMed ID: 17347482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis.
    Merched AJ; Chan L
    Circulation; 2004 Dec; 110(25):3830-41. PubMed ID: 15596565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A specific role for eNOS-derived reactive oxygen species in atherosclerosis progression.
    Takaya T; Hirata K; Yamashita T; Shinohara M; Sasaki N; Inoue N; Yada T; Goto M; Fukatsu A; Hayashi T; Alp NJ; Channon KM; Yokoyama M; Kawashima S
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1632-7. PubMed ID: 17463333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
    Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
    Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice.
    Miyoshi T; Li Y; Shih DM; Wang X; Laubach VE; Matsumoto AH; Helm GA; Lusis AJ; Shi W
    Life Sci; 2006 Jul; 79(6):525-31. PubMed ID: 16516241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement regulation in murine and human hypercholesterolemia and role in the control of macrophage and smooth muscle cell proliferation.
    Verdeguer F; Castro C; Kubicek M; Pla D; Vila-Caballer M; Vinué A; Civeira F; Pocoví M; Calvete JJ; Andrés V
    Cardiovasc Res; 2007 Nov; 76(2):340-50. PubMed ID: 17673191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice.
    Isoda K; Sawada S; Ishigami N; Matsuki T; Miyazaki K; Kusuhara M; Iwakura Y; Ohsuzu F
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1068-73. PubMed ID: 15059807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice.
    Chyu KY; Babbidge SM; Zhao X; Dandillaya R; Rietveld AG; Yano J; Dimayuga P; Cercek B; Shah PK
    Circulation; 2004 May; 109(20):2448-53. PubMed ID: 15136500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications.
    Chi H; Messas E; Levine RA; Graves DT; Amar S
    Circulation; 2004 Sep; 110(12):1678-85. PubMed ID: 15353494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose-6-phosphate dehydrogenase deficiency decreases vascular superoxide and atherosclerotic lesions in apolipoprotein E(-/-) mice.
    Matsui R; Xu S; Maitland KA; Mastroianni R; Leopold JA; Handy DE; Loscalzo J; Cohen RA
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):910-6. PubMed ID: 16439706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice.
    Merhi-Soussi F; Kwak BR; Magne D; Chadjichristos C; Berti M; Pelli G; James RW; Mach F; Gabay C
    Cardiovasc Res; 2005 Jun; 66(3):583-93. PubMed ID: 15914123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.
    Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice.
    Bengtsson E; To F; Håkansson K; Grubb A; Brånén L; Nilsson J; Jovinge S
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2151-6. PubMed ID: 16051881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice.
    Danenberg HD; Szalai AJ; Swaminathan RV; Peng L; Chen Z; Seifert P; Fay WP; Simon DI; Edelman ER
    Circulation; 2003 Aug; 108(5):512-5. PubMed ID: 12874178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of aortic remodeling in apolipoprotein E-deficient mice and renovascular hypertensive mice.
    Nogueira BV; Peotta VA; Meyrelles SS; Vasquez EC
    Arch Med Res; 2007 Nov; 38(8):816-21. PubMed ID: 17923260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
    Harrington SC; Simari RD; Conover CA
    Circ Res; 2007 Jun; 100(12):1696-702. PubMed ID: 17510462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exercise training reduces neointimal growth and stabilizes vascular lesions developing after injury in apolipoprotein e-deficient mice.
    Pynn M; Schäfer K; Konstantinides S; Halle M
    Circulation; 2004 Jan; 109(3):386-92. PubMed ID: 14699007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aorta of ApoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes.
    't Hoen PA; Van der Lans CA; Van Eck M; Bijsterbosch MK; Van Berkel TJ; Twisk J
    Circ Res; 2003 Aug; 93(3):262-9. PubMed ID: 12829615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.